Literature DB >> 20442284

In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis.

Elizabeth Gray1, Mark R Pett, Dawn Ward, David M Winder, Margaret A Stanley, Ian Roberts, Cinzia G Scarpini, Nicholas Coleman.   

Abstract

An important event in the development of cervical squamous cell carcinoma (SCC) is deregulated expression of high-risk human papillomavirus (HR-HPV) oncogenes, most commonly related to viral integration into host DNA. Mechanisms of development of the approximately 15% of SCCs that contain extrachromosomal (episomal) HR-HPV are poorly understood due to limited longitudinal data. We therefore used the W12 model to study mechanisms of cervical carcinogenesis associated with episomal HPV16. In vitro progression of W12 normally occurs through selection of cells containing integrated HPV16. However, in one long-term culture, keratinocytes developed a selective growth advantage and invasive phenotype while retaining HPV16 episomes at increased copy number in the absence of transcriptionally active integrants. Longitudinal investigations revealed similarities between the episome- and integrant-associated routes of neoplastic progression. Most notable were dynamic changes in viral early gene expression in episome-retaining cells, consistent with continually changing selective pressures. An early increase in viral transcription preceded elevated episome copy number and was followed by a reduction to near baseline after the development of invasiveness. Episomal transcriptional deregulation did not require selection of a specific sequence variant of the HPV16 upstream regulatory region, although increased levels of acetylated histone H4 around the late promoter implicated a role for altered chromatin structure. Interestingly, invasive episome-retaining cells showed high levels of HPV16 E2/E6 proteins (despite decreased transcript levels) and reduced expression of IFN-stimulated genes, adaptations that support viral persistence and cell survival. Our findings suggest a unified working model for events important in cervical neoplastic progression regardless of HR-HPV physical state. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20442284      PMCID: PMC2872760          DOI: 10.1158/0008-5472.CAN-09-3335

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes.

Authors:  R Klaes; S M Woerner; R Ridder; N Wentzensen; M Duerst; A Schneider; B Lotz; P Melsheimer; M von Knebel Doeberitz
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

2.  The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.

Authors:  K Webster; J Parish; M Pandya; P L Stern; A R Clarke; K Gaston
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  Differentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression.

Authors:  L M del Mar Peña; L A Laimins
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Rapid induction of senescence in human cervical carcinoma cells.

Authors:  E C Goodwin; E Yang; C J Lee; H W Lee; D DiMaio; E S Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Long-term effect of interferon on keratinocytes that maintain human papillomavirus type 31.

Authors:  Yijan E Chang; Loren Pena; Ganes C Sen; Jung K Park; Laimonis A Laimins
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.

Authors:  V Bouvard; G Matlashewski; Z M Gu; A Storey; L Banks
Journal:  Virology       Date:  1994-08-15       Impact factor: 3.616

Review 7.  The dynamics of keratin expression in malignant transformation of cervical epithelium: a review.

Authors:  F Smedts; F C Ramaekers; P G Vooijs
Journal:  Obstet Gynecol       Date:  1993-09       Impact factor: 7.661

8.  Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture.

Authors:  Michael J Lace; Christina Isacson; James R Anson; Attila T Lörincz; Sharon P Wilczynski; Thomas H Haugen; Lubomír P Turek
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

9.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Authors:  M H Stoler; C R Rhodes; A Whitbeck; S M Wolinsky; L T Chow; T R Broker
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

10.  The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1.

Authors:  M May; X P Dong; E Beyer-Finkler; F Stubenrauch; P G Fuchs; H Pfister
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  36 in total

1.  BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.

Authors:  Mary A Morse; Karla K Balogh; Sarah A Brendle; Colin A Campbell; Mao X Chen; Rebecca C Furze; Isobel L Harada; Ian D Holyer; Umesh Kumar; Kevin Lee; Rab K Prinjha; Martin Rüdiger; Jonathan T Seal; Simon Taylor; Jason Witherington; Neil D Christensen
Journal:  Antiviral Res       Date:  2018-04-11       Impact factor: 5.970

2.  HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.

Authors:  Vonetta M Williams; Maria Filippova; Ubaldo Soto; Penelope J Duerksen-Hughes
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

3.  HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.

Authors:  Francesca Paolini; Gianfranca Curzio; Marcelo Nazario Cordeiro; Silvia Massa; Luciano Mariani; Fulvia Pimpinelli; Antonio Carlos de Freitas; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 4.  Current state in the development of candidate therapeutic HPV vaccines.

Authors:  Andrew Yang; Jessica Jeang; Kevin Cheng; Ting Cheng; Benjamin Yang; T-C Wu; Chien-Fu Hung
Journal:  Expert Rev Vaccines       Date:  2016-03-07       Impact factor: 5.217

5.  Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.

Authors:  Michael J Lace; James R Anson; Jens P Klussmann; Dong Hong Wang; Elaine M Smith; Thomas H Haugen; Lubomir P Turek
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

6.  HPV episome levels are potently decreased by pyrrole-imidazole polyamides.

Authors:  Terri G Edwards; Kevin J Koeller; Urszula Slomczynska; Kam Fok; Michael Helmus; James K Bashkin; Chris Fisher
Journal:  Antiviral Res       Date:  2011-06-02       Impact factor: 5.970

Review 7.  Epithelial cell responses to infection with human papillomavirus.

Authors:  Margaret A Stanley
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Short- and long-range cis interactions between integrated HPV genomes and cellular chromatin dysregulate host gene expression in early cervical carcinogenesis.

Authors:  Ian J Groves; Emma L A Drane; Marco Michalski; Jack M Monahan; Cinzia G Scarpini; Stephen P Smith; Giovanni Bussotti; Csilla Várnai; Stefan Schoenfelder; Peter Fraser; Anton J Enright; Nicholas Coleman
Journal:  PLoS Pathog       Date:  2021-08-25       Impact factor: 6.823

9.  Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells.

Authors:  Ke-Di Wang; Dong-Jiang Xu; Bao-Ya Wang; Dong-Hui Yan; Zhi Lv; Jian-Rong Su
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

10.  HPV16 E2-mediated potentiation of NF-κB activation induced by TNF-α involves parallel activation of STAT3 with a reduction in E2-induced apoptosis.

Authors:  Devan Prabhavathy; Bandaru Niranjana Prabhakar; Devarajan Karunagaran
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.